Shivalik Rasayan
Shivalik Rasayan Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Shivalik Rasayan Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Shivalik Rasayan Ltd trades at a P/E of 32.33× and P/B of 0.77×.
Valuation
Profitability
Growth
Financial Health
Shivalik Rasayan Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Shivalik Rasayan Ltd, switchable between annual and quarterly views, consolidated or standalone.
Shivalik Rasayan Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹352.81 Cr and reported EPS of ₹8.88.
| Period | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 171 | 186 | 198 | 215 | 234 | 273 | 312 | 368 |
| Other Income | 8 | 3 | 1 | 4 | 5 | 4 | 8 | 4 |
| Total Income | 179 | 189 | 199 | 218 | 239 | 277 | 320 | 372 |
| Cost of Goods Sold (COGS) | 111 | 114 | 107 | 94 | 115 | 140 | 160 | 188 |
| Gross Profit | 59 | 73 | 91 | 121 | 120 | 133 | 151 | 180 |
| +Operating Expenses | 36 | 44 | 53 | 74 | 77 | 94 | 111 | 134 |
| EBITDA | 23 | 29 | 38 | 47 | 43 | 39 | 40 | 46 |
| +Non-Operating Expenses | 5 | 5 | 10 | 14 | 16 | 20 | 25 | 28 |
| Profit Before Tax (PBT) | 26 | 27 | 29 | 37 | 32 | 23 | 23 | 21 |
| +Tax Expense | 5 | 5 | 4 | 3 | 2 | 5 | 3 | 4 |
| Profit After Tax (PAT) | 21 | 22 | 25 | 34 | 30 | 18 | 20 | 18 |
| Earnings Per Share (EPS) | 15.20 | 16.00 | 18.00 | 23.64 | 20.59 | 10.51 | 10.60 | 7.71 |
| Diluted Shares Outstanding (Nos.) | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| +Additional Disclosures | 264 | 276 | 277 | 276 | 322 | 395 | 461 | 545 |
| Sales Growth % | — | 9.22 | 6.07 | 8.69 | 9.17 | 16.44 | 14.21 | 18.04 |
| YoY Sales Growth % | — | 9.22 | 6.07 | 8.69 | 9.17 | 16.44 | 14.21 | 18.04 |
| Material Cost % | 64 | 62 | 53 | 47 | 57 | 57 | 56 | 54 |
| Employee Cost % | 8 | 9 | 11 | 14 | 16 | 17 | 18 | 16 |
| Other Cost % | 13 | 15 | 16 | 21 | 17 | 17 | 18 | 20 |
| OPM % | 14 | 15 | 19 | 22 | 18 | 14 | 13 | 12 |
| Tax % | 20 | 17 | 14 | 7 | 6 | 22 | 13 | 16 |
| Profit Growth % | — | 5.24 | 12.52 | 38.09 | -12.90 | -39.43 | 13.01 | -12.02 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 20 | 25 | 29 | 36 | 31 | 27 | 24 | 27 |
Shivalik Rasayan segment analysis: revenue and profit mix.
Disclosed business segments at Shivalik Rasayan with their share of revenue and profit, switchable between consolidated and standalone reporting.
Shivalik Rasayan discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Shivalik Rasayan Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Shivalik Rasayan Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Shivalik Rasayan Ltd's investment case rests on 9 positive markers and 9 flagged concerns drawn from the latest reported filings.
What you're getting.
Debt-to-equity ratio is very low at 0.18, indicating strong financial health.
Consistent revenue growth. 5-year CAGR of 10.85% and 3-year CAGR of 13.23%.
Robust quarterly sales growth of 19.70% demonstrates strong recent market demand.
Diversified product portfolio across Agrochemicals and Pharmaceutical APIs mitigates risks.
Increasing FII confidence, with holdings rising from 0.04% to 4.38% recently.
What can break it.
Low profitability ratios. ROE 1.56% and ROCE 5.51% indicate inefficient capital use.
Sharp quarterly profit decline of -54.60% raises concerns about recent performance.
High P/E ratio of 43.76 appears overvalued compared to sector P/E 42.07.
Negative EPS growth over 3 years (-16.36%) and low 5-year growth (0.84%).
Negative annual cash flow per share (-20.46) indicates poor operational cash generation.
What would change my mind.
Trim if P/E re-rates above 42. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Shivalik Rasayan Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Shivalik Rasayan Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Shivalik Rasayan Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Shivalik Rasayan Ltd — derived from the live tape, not yesterday's close.
Shivalik Rasayan Ltd last traded at ₹252.5 with an intraday range of ₹250.1–₹275.7 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹252.50| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 319.97 | +67.47 | +26.72% |
| R3 | 294.37 | +41.87 | +16.58% |
| R2 | 285.03 | +32.53 | +12.88% |
| R1 | 268.77 | +16.27 | +6.44% |
| PIVOT | 259.43 | 6.93 | 2.75% |
| CURRENT | 252.50 | — | — |
| S1 | 191.97 | -60.53 | -23.97% |
| S2 | 217.57 | -34.93 | -13.83% |
| S3 | 233.83 | -18.67 | -7.39% |
| S4 | 243.17 | -9.33 | -3.70% |
SHIVALIK is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ~
Trading Below opening range, showing Bearishness
Shivalik Rasayan Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Shivalik Rasayan Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Shivalik Rasayan Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Shivalik Rasayan Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Shivalik Rasayan Ltd stood at 62.3% of traded volume, against a 20-day average of 53.8%.
Shivalik Rasayan announcements: results, concalls, ratings, M&A.
Filings Shivalik Rasayan sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Shivalik Rasayan files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 29 documents below.
Trading Plan under PIT
Shivalik Rasayan Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Copy of Newspaper Publication
Shivalik Rasayan Limited has informed the Exchange about Copy of Newspaper Publication
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Shivalik Rasayan Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Copy of Newspaper Publication
Shivalik Rasayan Limited has informed the Exchange about Copy of Newspaper Publication
Outcome of Board Meeting
Shivalik Rasayan Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Shivalik Rasayan dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Shivalik Rasayan has declared, sequenced by announce and record date.
Shivalik Rasayan corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Shivalik Rasayan Ltd: business, sector, key facts.
What Shivalik Rasayan Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Shivalik Rasayan Ltd operates in the Chemicals industry under the Materials sector, listed as NSE: SHIVALIK, BSE: 539148.
Shivalik Rasayan Limited (SRL) is an Indian chemical manufacturing company primarily focused on the production and sale of agrochemicals and pharmaceutical ingredients. A significant portion of their business involves the creation of plant protection chemicals for the agricultural sector. This includes the manufacture of key active ingredients such as Dimethoate technical and Malathion technical. Dimethoate technical serves as a base for creating formulations used to control insects and mites affecting various crops, while Malathion technical, an organophosphate insecticide, finds application in controlling pests on numerous food and feed crops. Their expertise extends to the broader manufacturing of organophosphorus-based insecticides and other related chemicals.
Beyond agrochemicals, SRL also plays a substantial role in the pharmaceutical industry. They are involved in the research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs). These APIs cater to a diverse range of therapeutic areas, including oncology (cancer treatment), antiretroviral drugs (ARVs) used to combat HIV/AIDS, cardiovascular medications, treatments for metabolic disorders, and immunology-related drugs. This diversification into pharmaceutical APIs significantly broadens SRL’s product portfolio and market reach.
In addition to their own product lines, SRL offers custom chemical manufacturing services. This aspect of their business allows them to cater to the specific needs of other companies requiring specialized chemical synthesis or formulation. This contract manufacturing capability adds another revenue stream and demonstrates their flexibility and expertise in chemical processing. The company's established infrastructure and experience in chemical production likely make them a competitive choice for companies outsourcing their manufacturing needs.
Established in 1979 and headquartered in New Delhi, India, Shivalik Rasayan Limited has a long history in the chemical industry. Their integrated approach encompassing both agrochemicals and pharmaceutical APIs positions them uniquely in the Indian market. This strategy allows for potential synergies between their divisions, and diversification mitigates risks associated with relying heavily on any single market sector. The company's continued success will likely depend on its ability to innovate, adapt to evolving market demands, and maintain its competitive edge in both the agricultural and pharmaceutical sectors.
Questions investors ask about Shivalik Rasayan Ltd (SHIVALIK).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Shivalik Rasayan Ltd (SHIVALIK)?
The current share price of Shivalik Rasayan Ltd (SHIVALIK) is ₹252.5. Today, the stock has declined by ₹18.80 (6.93%), trading in a range of ₹250.1 to ₹275.7. The stock opened at ₹275.7 with a trading volume of 1,11,906 shares.
02Is Shivalik Rasayan Ltd stock a good investment for long-term?
Shivalik Rasayan Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹352.81 crores, P/E ratio of 32.33, ROE of 1.28%, and ROCE of 5.51%. The dividend yield stands at 0.62%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Shivalik Rasayan Ltd stock?
The 52-week high price of Shivalik Rasayan Ltd (SHIVALIK) is ₹651, while the 52-week low is ₹206.75. Currently trading at ₹252.5, the stock is 10.3% away from its 52-week low and 61.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Shivalik Rasayan Ltd stock at the current price?
Whether to buy Shivalik Rasayan Ltd stock at ₹252.5 depends on multiple factors. The stock is currently trading with a P/E ratio of 32.33 and P/B ratio of 0.77. Today's performance shows a loss of 6.93%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Shivalik Rasayan Ltd and when is the next dividend?
Shivalik Rasayan Ltd offers a dividend yield of 0.62%, which means for every ₹100 invested at the current price of ₹252.5, you can expect to receive approximately ₹0.62 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Shivalik Rasayan Ltd?
Shivalik Rasayan Ltd's key financial metrics include: P/E Ratio: 32.33, P/B Ratio: 0.77, ROE: 1.28%, ROCE: 5.51%, Dividend Yield: 0.62%, EPS: ₹8.88, Book Value: ₹266.79, and Debt-to-Equity: 0.25. The company's market cap stands at ₹352.81 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Shivalik Rasayan Ltd stock performing today in the market?
Shivalik Rasayan Ltd stock opened at ₹275.7 and is currently trading at ₹252.5, showing a decline of ₹18.80 (6.93%). The intraday high is ₹275.7 and low is ₹250.1. The trading volume stands at 1,11,906 shares, indicating moderate market participation today.
08What is the P/E ratio of Shivalik Rasayan Ltd and what does it indicate?
Shivalik Rasayan Ltd has a Price-to-Earnings (P/E) ratio of 32.33, which means investors are willing to pay ₹32.33 for every ₹1 of earnings. With an EPS of ₹8.88, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Shivalik Rasayan Ltd (SHIVALIK) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Astec Lifesciences (ASTEC) Share PricePeer
- Bhagiradha Chemicals & Industries (BHAGCHEM) Share PricePeer
- Bharat Rasayan (BHARATRAS) Share PricePeer
- Dhanuka Agritech (DHANUKA) Share PricePeer
- Dharmaj Crop Guard (DHARMAJ) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy